References
- Kerl H, Cerroni L. Primary B-cell lymphomas of the skin. Ann Oncol 1997; 8(suppl 2)29–32
- Pimpinelli N, Santucci M, Mori M, Vallecchi C, Giannotti B. Primary cutaneous B-cell lymphoma: A clinically homogeneous entity?. J Am Acad Dermatol 1997; 37: 1012–6
- Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354–71
- Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, et al. Updated Kiel classification for lymphomas. Lancet 1998;1:292–3 (letter).
- Willemze R, Meijer CJLM, Scheffer E. Diffuse large cell lymphomas of follicle center cell origin presenting in the skin: A clinicopathologic and immunologic study of 16 patients. Am J Pathol 1987; 126: 325–33
- Vermeer MH, Geelen FAMJ, van Haselen CW. Primary cutaneous large B-cell lymphomas of the legs: A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 1996; 132: 1304–08
- Grange F, Hedelin G, Joly P, Beylot-Barry M, D'Incan M, Delaunay M, et al. Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. Blood 1999; 93: 3637–42
- Jaffe ES, Harris NL, Stein H, Vardiman W, et al. World Health Organization classification of tumors: Pathology and genetics of tumours of hematopoietic and lymphoid tissues. LyonFrance: IARC Press; 2001.
- Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Review article. Blood 2005; 105: 3768–85
- Grange F, Bekkenk MW, Wechsler J, Meijer CJLM, Cerroni L, Bernengo M, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study. J Clin Oncol 2001; 19: 3602–10
- Kodama K, Massone C, Chott A, Metze D, Kerl H, Cerroni L. Primary cutaneous large B-cell lymphomas: Clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005; 106: 2491–7
- Chang Y, Moore PS. Kaposi's Sarcoma (KS) – associated herpesvirus and its role in KS. Infect Agents Dis 1996; 5: 215–22
- Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, et al. Primary effusion lymphoma in women: Report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996; 88: 3124–8
- Geelen FAMJ, Vermeer MH, Meijer CJLM, Van der Putte SCJ, Kerkhof E, Kluin PM, et al. Bcl-2 expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 1998; 16: 2080–5
- Hoefnagel JJ, Vermeer MH, Janssen PM, Fleuren GJ, Meijer CJ, Willemze R. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: Further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol 2003; 149: 1183–91
- Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005; 105: 3671–8
- Mao X, Lillington D, Child FJ, Russell-Jones R, Young B, Whittaker S. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: Identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 2002; 35: 144–55
- Hallermann C, Kaune KM, Gesk S, Martin-Subero J.I. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6 and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 2004; 123: 213–9